[Fehorizon Ushers in the 3.0 Era] Portfolio Company of FE ZENITH CAPITAL, Insight Lifetech, Successfully Lists on the STAR Market of Shanghai Stock Exchange
On February 5, Insight Lifetech Co., Ltd. (hereinafter referred to as "Insight Lifetech", 688712.SH), a portfolio company of FE ZENITH CAPITAL—a wholly-owned specialized private equity investment institution under FEHORIZON—successfully listed on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. Insight Lifetech has become the first medical device enterprise to successfully go public under the fifth set of listing standards of the STAR Market after their reinstatement, and it is also the first medical device company to successfully list on the STAR Market since 2024.

Founded in 2015 and headquartered in Shenzhen, Insight Lifetech is a representative of independent innovation among domestic medical device enterprises. Its core products, the IVUS (Intravascular Ultrasound) system and FFR (Fractional Flow Reserve) system, have received positive clinical feedback and demonstrated excellent market performance. The company's Pulsed Field Ablation (PFA) system has become the first PFA product from China selected for breakthrough clinical research progress at the European Society of Cardiology Annual Congress, and its clinical results have been published in JACC, a top international journal in the cardiovascular field.
The team at FE ZENITH CAPITAL has consistently tracked the development of Insight Lifetech, investing in two consecutive rounds to support the company's growth. On the listing day, Insight Lifetech's issue price was 17.52 yuan per share, and the opening price was 50.31 yuan, representing an increase of 187.16% compared to the issue price. Calculated based on the opening price, the company's market value exceeded 20 billion yuan.

As a specialized private equity investment institution under FEHORIZON, FE ZENITH CAPITAL has always focused on equity investments in fields such as technological innovation, advanced manufacturing, and healthcare, aiming to enhance the value of its portfolio companies. In the future, FE ZENITH CAPITAL will continue to deeply integrate the financial and industrial resources within the FEHORIZON system, leveraging the Group's profound resource advantages and adopting a combined equity-debt approach to assist high-quality enterprises with core technologies and broad commercial prospects in achieving high-quality development.
